SCHEMBL989427

SCHEMBL989427

CC(C)CCCCC([O])=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.46
KDM4A O75164 1/20 0.46
PHF8 Q9UPP1 1/20 0.46
KDM2A Q9Y2K7 1/20 0.46
CA1 P00915 2/20 0.44
LMNA P02545 1/20 0.43
BLM P54132 1/20 0.41
LTA4H P09960 1/20 0.38
DEGS1 O15121 1/20 0.37
KDM1A O60341 1/20 0.36
FFAR4 Q5NUL3 1/20 0.34
FFAR1 O14842 1/20 0.34
PTPN1 P18031 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
RARB P10826 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19458576 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL8811627 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL8883594 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL7840095 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL10802912 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL6060606 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL10800219 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL10799228 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL5500233 0.97 KDM4C (0.48) KDM4CKDM4APHF8KDM2ACA1
SCHEMBL276797 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114014878-B Conjugated alkenyl zinc reagent, preparation method and application thereof 南开大学 2024-06-07 CN claimed
CN-116535439-B Cyclopropane skeleton monophosphine ligand and palladium complex thereof, and preparation method and application thereof 南开大学 2024-05-28 CN claimed
CN-116535439-A Cyclopropane skeleton monophosphine ligand and palladium complex thereof, and preparation method and application thereof 南开大学 2023-08-04 CN claimed
WO-2023142725-A1 CYCLOPROPANE SKELETON MONOPHOSPHINE LIGAND AND PALLADIUM COMPLEX THEREOF AS WELL AS PREPARATION METHOD AND USE THEREOF 南开大学 2023-08-03 WO claimed
CN-116003462-A Silicon-based substituted chiral amine and preparation method and application thereof 南开大学 2023-04-25 CN claimed
CN-115850328-A Diphosphine ligand with cyclopropane skeleton and cobalt complex thereof, preparation method and application 南开大学 2023-03-28 CN claimed
US-20220162219-A1 Chiral Bisamino-Ether Compounds, And Method of Preparation and Use Thereof UNIV JINAN (CN) 2022-05-26 US claimed
CN-114249725-A Preparation method and application of 2-imine-9-aryl substituted phenanthroline and iron complex thereof 南开大学 2022-03-29 CN claimed
CN-114014878-A Novel conjugated alkenyl zinc reagent, preparation method and application thereof 南开大学 2022-02-08 CN claimed
CN-106518931-B Novel iridium complex of spiro phosphine-carboxylic acid and preparation method and application thereof 南开大学 2021-08-24 CN claimed
US-20140194638-A1 Spirobenzylamine-Phosphine, Preparation Method Therefor And Use Thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2014-07-10 US claimed
EP-2752419-A1 SPIROBENZYLAMINE-PHOSPHINE, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2014-07-09 EP claimed
US-8450493-B2 Spiro phosphine-oxazoline, preparation method and application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2013-05-28 US claimed
US-20110118472-A1 Spiro Phosphine-Oxazoline, Preparation Method and Application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-05-19 US claimed
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-04-21 US claimed
EP-2275398-A1 APPLICATION OF THE IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION FOR UNSATURATED CARBOXYLIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-19 EP claimed
EP-2272853-A1 SPIRO PHOSPHORUS-OXAZOLINE, SYNTHESIS AND USE THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-12 EP claimed
EP-0329361-B1 2-pyranone derivatives and process for production thereof SUNTORY LTD (JP) 1995-12-06 EP claimed
US-5021406-A Side-effect-reduced microbiocides and fungicides; controlling botrytic mold SUNTORY LIMITED (JP) 1991-06-04 US claimed
EP-0329361-A2 2-pyranone derivatives and process for production thereof SUNTORY LIMITED (JP) 1989-08-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS HDHD5, ELOVL5, FASN KDM4C 4751/4885KDM4A 4813/4885PHF8 1115/4885
US-20220162219-A1 Chiral Bisamino-Ether Compounds, And Method of Preparation and Use Thereof FHIT, BCAT1, BCAT2 KDM4C 1485/4885KDM4A 1367/4885PHF8 603/4885
US-20140194638-A1 Spirobenzylamine-Phosphine, Preparation Method Therefor And Use Thereof FAR1, WEE1, ALDH7A1 KDM4C 3226/4885KDM4A 3485/4885PHF8 1749/4885
US-20110118472-A1 Spiro Phosphine-Oxazoline, Preparation Method and Application thereof ADH1A, ADH1C, ALDH7A1 KDM4C 3137/4885KDM4A 3848/4885PHF8 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.